Growth hormone variants: A potential avenue for a better diagnostic characterization of growth hormone deficiency in children

Journal of Endocrinological Investigation

Volumn 35, Issue 10, 2012, Pages 937-944

  Rigamonti, A E ^a   Bozzola, M ^b   Banfi, G ^a   Meazza, C ^b   Muller E E ^a   Cella, S G ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Analytical methods; Biochemical diagnosis; GH deficiency; GH isoforms; Growth hormone

Indexed keywords

GROWTH HORMONE BINDING PROTEIN; GROWTH HORMONE DERIVATIVE; GROWTH HORMONE V; HUMAN GROWTH HORMONE; MONOCLONAL ANTIBODY; OLIGOMER; POLYCLONAL ANTIBODY; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ACYLATION; BIOASSAY; CHEMOLUMINESCENCE; DEAMINATION; DRUG ELIMINATION; GENETIC HETEROGENEITY; GLYCOSYLATION; GROWTH HORMONE DEFICIENCY; HORMONE DETERMINATION; HUMAN; IMMUNOASSAY; IMMUNORADIOMETRIC ASSAY; INSULIN TOLERANCE TEST; METABOLISM; NONHUMAN; PHOSPHORYLATION; RADIOIMMUNOASSAY; REVIEW; RNA SPLICING; URINARY EXCRETION;

BIOLOGICAL ASSAY; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; MULTIGENE FAMILY; PROTEIN ISOFORMS;

EID: 84871874880     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/8647     Document Type: Review

References (73)

1. Andersson AM, Orskov H, Ranke MB, Shalet S, Skakkebaek NE. Interpretation of growth hormone provocative tests: comparison of cut-off values in four European laboratories. Eur J Endocrinol 1995, 132: 340-3.
2. Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone deficiency J Clin Endocrinol Metab 1998, 83: 379-381.
3. Ebdrup L, Fisker S, Sørensen HH, Ranke MB, Orskov H. Variety in growth hormone determinations due to use of different immunoassays and to the interference of growth hormone-binding protein. Horm Res 1999, 51 (Suppl 1): 20-6. (Pubitemid 29301279)
4. Ranke MB, Orskov H, Bristow AF, Seth J, Baumann G. Consensus on how to measure growth hormone in serum. Horm Res 1999, 51 (Suppl 1): 27-9. (Pubitemid 29301280)
5. Jansson C, Boguszewski C, Rosberg S, Carlsson L, Albertsson- Wikland K. Growth hormone (GH) assays: influence of standard preparations, GH isoforms, assay characteristics, and GH-binding protein. Clin Chem 1997, 43: 950-6. (Pubitemid 27246984)
6. Baumann G. Growth hormone heterogeneity in human pituitary and plasma. Horm Res 1999, 51 (Suppl 1): 2-6. (Pubitemid 29301276)
7. Clemmons DR. Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays. Clin Chem 2011, 57: 555-9.
8. Popii V, Baumann G. Laboratory measurement of growth hormone. Clin Chim Acta 2004, 350: 1-16. (Pubitemid 39458242)
9. Baumann GP. Growth hormone isoforms. Growth Horm IGF Res 2009, 19: 333-40.
10. Chen EY, Liao YC, Smith DH, Barrera-Saldaña HA, Gelinas RE, Seeburg PH. The human growth hormone locus: nucleotide sequence, biology, and evolution. Genomics 1989, 4: 479-97.
11. Baxter JD, Seeburg PH, Shine J, Martial JA, Goodman HM. The gene for growth hormone (GH): DNA sequence, expression, regulation. Clin Res 1977, 25: 461A.
12. Masuda N, Watahiki M, Tanaka M, et al. Molecular cloning of cDNA encoding 20 kDa variant human growth hormone and the alternative splicing mechanism. Biochim Biophys Acta 1988, 949: 25-31.
13. Petkovic V, Lochmatter D, Turton J, et al. Exon splice enhancer mutation (GH-E32A) causes autosomal dominant growth hormone deficiency. J Clin Endocrinol Metab 2007, 92: 4427-35. (Pubitemid 350074766)
14. Hill DJ. What is the role of growth hormone and related peptides in implantation and the development of the embryo and fetus. Horm Res 1992, 38 (Suppl 1): 28-34. (Pubitemid 23061874)
15. Handwerger S. The growth hormone gene cluster: physiological actions and regulation during pregnancy. Growth Gen Horm 2009, 25: 1-8.
16. Kratzsch J, Selisko T, Birkenmeier G. Identification of transformed alpha 2-macroglobulin as a growth hormone-binding protein in human blood. J Clin Endocrinol Metab 1995, 80: 585-90.
17. Wells JA. Binding in the growth hormone receptor complex, Proc Natl Acad Sci U S A 1996, 93: 1-6. (Pubitemid 26038094)
18. De Palo EF, De Filippis V, Gatti R, Spinella P. Growth hormone isoforms and segments/fragments: molecular structure and laboratory measurement. Clin Chim Acta 2006, 364: 67-76. (Pubitemid 43124017)
19. Smal J, Closset J, Hennen G, de Meyts P. Receptor-binding and down-regulatory properties of 22000-Mr human growth hormone and its natural 20000-Mr variant on IM-9 human lymphocytes. Biochem J 1985, 225: 283-9. (Pubitemid 15162171)
20. Hansen BS, Hjorth S, Welinder BS, Skriver L, De Meyts P. The growth hormone (GH)-binding protein cloned from human IM-9 lymphocytes modulates the down-regulation of GH receptors by 22- and 20-kilodalton human GH in IM-9 lymphocytes and the biological effects of the hormone in Nb2 lymphoma cells. Endocrinology 1993, 133: 2809-17. (Pubitemid 24000740)
21. Wada M, Ikeda M, Takahashi Y, et al. The full agonistic effect of recombinant 20 kDa human growth hormone (hGH) on CHO cells stably transfected with hGH receptor cDNA. Mol Cell Endocrinol 1997, 133: 99-107. (Pubitemid 27491522)
22. Skottner A, Forsman A, Skoog B, et al. Biological characterization of charge isomers of human growth hormone. Acta Endocrinol (Copenh) 1988, 118: 14-21.
23. Liberti JP, Antoni BA, Chlebowski JF. Naturally-occurring pituitary growth hormone is phosphorylated. Biochem Biophys Res Commun 1985, 128: 713-20. (Pubitemid 15004507)
24. Liberti JP, Joshi GS. Synthesis and secretion of phosphorylated growth hormone by rat pituitary glands in vitro. Biochem Biophys Res Commun 1986, 137: 806-12. (Pubitemid 16044459)
25. Zhan X, Giorgianni F, Desiderio DM. Proteomics analysis of growth hormone isoforms in the human pituitary. Proteomics 2005, 5: 1228-41.
26. Ray J, Jones BK, Liebhaber SA, Cooke NE. Glycosylated human growth hormone variant. Endocrinology 1989, 125: 566-8. (Pubitemid 19182710)
27. Baumann G. Growth hormone heterogeneity: genes, isohormones, variants, and binding proteins. Endocr Rev 1991, 12: 424-49.
28. Lewis UJ, Peterson SM, Bonewald LF, Seavey BK, VanderLaan WP. An interchain disulfide dimer of human growth hormone. J Biol Chem 1977, 252: 3697-702. (Pubitemid 8116104)
29. Brostedt P, Roos P. Isolation of dimeric forms of human pituitary growth hormone, Prep. Biochem 1989, 19: 217-29. (Pubitemid 20062391)
30. Lewis UJ, Sinha YN, Lewis GP. Structure and properties of members of the hGH family: a review. Endocr J 2000, 47 (Suppl): S1-8. (Pubitemid 30243424)
31. Such-Sanmartín G, Bosch J, Segura J, Gutiérrez-Gallego R. Generation of 5 and 17 kDa human growth hormone fragments through limited proteolysis. Growth Factors 2009, 27: 255-64.
32. Johnson V, Maack T. Renal extraction, filtration, absorption, and catabolism of growth hormone. Am J Physiol 1977, 233: F185-96.
33. Such-Sanmartín G, Bosch J, Segura J, Gutiérrez-Gallego R. Generation of 5 and 17 kDa human growth hormone fragments through limited proteolysis. Growth Factors 2009, 27: 255-64.
34. Baumann G, Abramson EC. Urinary growth hormone in man: evidence for multiple molecular forms. J Clin Endocrinol Metab 1983, 56: 305-11. (Pubitemid 13184368)
35. Dattani MT, Hindmarsh PC, Pringle PJ, Brook CG, Marshall NJ. The measurement of growth hormone bioactivity in patient serum using an eluted stain assay. J Clin Endocrinol Metab 1995, 80: 2675-83.
36. Ilondo MM, Vanderschueren-Lodeweyckx M, De Meyts P, Eggermont E. Serum growth hormone levels measured by radioimmunoassay and radioreceptor assay: a useful diagnostic tool in children with growth disorders? J Clin Endocrinol Metab 1990, 70: 1445-51.
37. Bidlingmaier M, Freda PU. Measurement of human growth hormone by immunoassays: current status, unsolved problems and clinical consequences. Growth Horm IGF Res 2010, 20: 19-25.
38. Banfi G, Casari E, Murone M, Bonini P. Discrepancies among commercial kits for assaying growth hormone. Clin Chem 1990, 36: 402. (Pubitemid 20083914)
39. Banfi G, Marinelli M, Casari E, Murone M, Bonini P. Isotopic and nonisotopic assays for measuring somatotropin compared: re-evaluation of cutoff value in provocative tests. Clin Chem 1991, 37: 273-6. (Pubitemid 21892643)
40. Wood P. Growth hormone: its measurement and the need for assay harmonization. Ann Clin Biochem 2001, 38: 471-82. (Pubitemid 32846052)
41. Strasburger CJ, Wu Z, Pflaum CD, Dressendörfer RA. Immunofunctional assay of human growth hormone (hGH) in serum: a possible consensus for quantitative hGH measurement. J Clin Endocrinol Metab 1996, 81: 2613-20. (Pubitemid 26240286)
42. Trainer PJ, Barth J, Sturgeon C, Wieringaon G. Consensus statement on the standardisation of GH assays. Eur J Endocrinol 2006, 155: 1-2. (Pubitemid 44103367)
43. Banfi G, Marinelli M, Pontillo M, Bonini P. Standardization with synthetic 22-kDa monomer human growth hormone reduces discrepancies between two monoclonal immunoradiometric assay kits. Clin Chem 1992, 38: 2107-10.
44. Boguszewski CL, Johannsson G, Bengtsson BA, Johansson A, Carlsson B, Carlsson LM. Circulating non-22-kilodalton growth hormone isoforms in acromegalic men before and after transsphenoidal surgery. J Clin Endocrinol Metab 1997, 82: 1516-21. (Pubitemid 27200428)
45. Boguszewski CL, Hynsjö L, Johannsson G, Bengtsson BA, Carlsson LM. 22-kD growth hormone exclusion assay: a new approach to measurement of non-22 kD growth hormone isoforms in human blood. Eur J Endocrinol 1996, 135: 573-82. (Pubitemid 26396282)
46. Uchida H, Naito N, Asada N, et al. Secretion of authentic 20-kDa human growth hormone (20 K hGH) in Escherichia coli and properties of the purified product. J Biotechnol 1997, 55: 101-2.
47. Tsushima T, Katoh Y, Miyachi Y, et al. Serum concentration of 20 K human growth hormone (20K hGH) measured by a specific enzyme- linked immunosorbent assay. J Clin Endocrinol Metab 1999, 84: 317-22. (Pubitemid 29036719)
48. Ishikawa M, Yokoya S, Tachibana K, et al. Serum levels of 20-kilodalton human growth hormone (GH) are parallel those of 22-kilodalton human GH in normal and short children. J Clin Endocrinol Metab 1999, 84: 98-104. (Pubitemid 29036686)
49. Irie M, Ueki M, Kishikawa Y, Nishii M, Kawahara T. 20K-GH and its use in detecting GH abuse. Growth Horm IGF Res 1999, 19: 352-6.
50. Wu Z, Bidlingmaier M, Dall R, Strasburger CJ. Detection of doping with human growth hormone. Lancet 1999, 353: 895. (Pubitemid 29126879)
51. Bidlingmaier M, Suhr J, Ernst A, et al. High-sensitivity chemiluminescence immunoassays for detection of growth hormone doping in sports. Clin Chem 2009, 55: 445-53.
52. Hansen TK, Fisker S, Hansen B, et al. Impact of GHBP interference on estimates of GH and GH pharmacokinetics. Clin Endocrinol 2002, 57: 779-86. (Pubitemid 36963006)
53. Hernández LM, Lee PD, Camacho-Hübner C. Isolated growth hormone deficiency. Pituitary 2007, 10: 351-7. (Pubitemid 350130581)
54. Rapaport R, Bowlby DA. Clinical aspects of growth and growth disorders, In: Pescovitz OH, Eugster AE (eds). Pediatric Endocrinology. Mechanisms, manifestations, and management. Philadelphia, PA: Lippincott Williams & Wilkins. 2004, p. 178.
55. Bozzola M, Meazza C. Growth hormone deficiency: diagnosis and therapy in children. Expert Rev Endocrinol Metab 2010, 5: 273-84.
56. Growth Hormone Research Society. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society. J Clin Endocrinol Metabol 2000, 85: 3990-3.
57. Richmond EJ, Rogol AD. Growth hormone deficiency in children. Pituitary 2008, 11: 115-20.
58. Meazza C, Albertini R, Pagani S, et al. Diagnosis of growth hormone (GH) deficiency is affected by calibrators used in GH immunoassays. Horm Metab Res 2012, Jun 6 [Epub ahead of print]; doi: 10.1055/s-0032-1314855.
59. Tenenbaum-Rakover Y. The need to revise the cut-off level for the diagnosis of GH deficiency in children. Pediatr Endocrinol Rev 2008, 5: 880-8.
60. Juul A, Bernasconi S, Clayton PE, Kiess W, DeMuinck-Keizer Schrama S; Drugs and Therapeutics Committee of the European Society for Paediatric Endocrinology (ESPE). European audit of current practice in diagnosis and treatment of childhood growth hormone deficiency. Horm Res 2002, 58: 233-41. (Pubitemid 36158554)
61. Mazzola A, Meazza C, Travaglino P, et al. Unreliability of classic provocative tests for the diagnosis of growth hormone deficiency. J Endocrinol Invest 2008, 31: 159-62. (Pubitemid 351596977)
62. Ghigo E, Bellone J, Aimaretti G, et al. Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children. J Clin Endocrinol Metab 1996, 81: 3323-7. (Pubitemid 26296210)
63. Obara-Moszynska M, Kedzia A, Korman E, Niedziela M. Usefulness of growth hormone (GH) stimulation tests and IGF-1 concentration measurement in GH deficiency diagnosis. J Pediatr Endocrinol Metab 2008, 21: 569-79.
64. Badaru A, Wilson DM. Alternatives to growth hormone stimulation testing in children. Trends Endocrinol Metab 2004, 15: 252-8. (Pubitemid 39044198)
65. Kowarski AA, Schneider J, Ben-Galim E, Weldon VV, Daughaday WH. Growth failure with normal serum RIA-GH and low somatomedin activity: somatomedin restoration and growth acceleration after exogenous GH. J Clin Endocrinol Metab 1978, 47: 461-4. (Pubitemid 8393552)
66. Travaglino P, Buzi F, Meazza C, et al. Response to long-term growth hormone therapy in short children with reduced GH bioactivity. Horm Res 2006, 66: 189-94. (Pubitemid 44413280)
67. Pagani S, Meazza C, Laarej K, Cantoni F, Bozzola M. Efficacy of long-term growth hormone (GH) therapy in short children with reduced GH biological activity. J Endocrinol Invest 2011, 34: 366-9.
68. Takahashi Y, Shirono H, Arisaka O, et al. Biologically inactive growth hormone caused by an amino acid substitution. J Clin Invest 1997, 100: 1159-65. (Pubitemid 27386300)
69. Besson A, Salemi S, Deladoëy J, et al. Short stature caused by a biologically inactive mutant growth hormone (GH-C53S). J Clin Endocrinol Metab 2005, 90: 2493-9. (Pubitemid 40686282)
70. Hauffa BP, Lehmann N, Bettendorf M, et al German KIGS/IGLU Study Group. Central reassessment of GH concentrations measured at local treatment centers in children with impaired growth: consequences for patient management. Eur J Endocrinol 2004, 150: 291-7. (Pubitemid 38443778)
71. Ross HA; Endocrinology section and project group "Calibration 2000" of the SKML (Dutch Foundation for Quality Assessment in Clinical Laboratories). Reporting growth hormone assay results in terms of one consensus recombinant standard preparation offers less than optimal reduction of between-method variation. Clin Chem Lab Med 2008, 46: 1334-5.
72. Sheppard MC. Growth hormone assay standardization: an important clinical advance. Clin Endocrinol (Oxf) 2007, 66: 157-61. (Pubitemid 46096133)
73. Pokrajac A, Wark G, Ellis AR, Wear J, Wieringa GE, Trainer PJ. Variation in GH and IGF-I assays limits the applicability of international consensus criteria to local practice. Clin Endocrinol (Oxf) 2007, 67: 65-70. (Pubitemid 46955441)